Dot Therapeutics-1, Inc.
Records under this name other than patents Dot Therapeutics-1, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Dot Therapeutics-1, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,802,657 | Compounds Useful as Raf Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,556,177 | Substituted 1,3-Thiazoles as Synthetic Intermediates for Preparation of Raf Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,920,048 | Substituted Pyrimidines for Inhibiting Raf Kinase Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,293,752 | Compounds Useful as Raf Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 10,426,782 | Pharmaceutical Formulations of a Pan-Raf Kinase Inhibitor and Processes for Their Preparation Formerly held In force · High confidence | In force | High confidence | |
| US 10,988,469 | Method for Producing Optically Active Compound Formerly held In force · High confidence | In force | High confidence | |
| US 12,129,249 | Method for Producing Optically Active Compound Formerly held In force · Medium confidence | In force | Medium confidence |